SAP-021

N/A

Report date: 2025/06/18 13:55:53

Base Information

Drug NameSAP-021
Drug Alias NameSAP021SAP-021AVAT-021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsNervous System DiseasesFasciitis, Plantar
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvata Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvata Biosciences LtdOceanus Bio IncAzienda Ospedaliero-Universitaria Consorziale
Inactive CompaniesN/A
Active IndicationsNervous System DiseasesFasciitis, Plantar
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A